open access

Vol 27, No 2 (2021)
Commentary
Get Citation

Komentarz do wytycznych postępowania w przypadku przewlekłych schorzeń żylnych kończyn dolnych ― „Zapobieganie zespołowi pozakrzepowemu” pod redakcją Andrew Nicolaidesa i wsp.

Zbigniew Krasiński, Andrzej Jawień
DOI: 10.5603/AA.2021.0007
·
Acta Angiologica 2021;27(2):37-40.

open access

Vol 27, No 2 (2021)
Commentary

Abstract

Not available

Abstract

Not available
Get Citation
About this article
Title

Komentarz do wytycznych postępowania w przypadku przewlekłych schorzeń żylnych kończyn dolnych ― „Zapobieganie zespołowi pozakrzepowemu” pod redakcją Andrew Nicolaidesa i wsp.

Journal

Acta Angiologica

Issue

Vol 27, No 2 (2021)

Article type

Commentary

Pages

37-40

Page views

2695

Article views/downloads

232

DOI

10.5603/AA.2021.0007

Bibliographic record

Acta Angiologica 2021;27(2):37-40.

Authors

Zbigniew Krasiński
Andrzej Jawień

References (17)
  1. Nicolaides A, Kakkos S, Baekgaard N, et al. Management of chronic venous disorders of the lower limbs. Guidelines According to Scientific Evidence. Part II. Int Angiol. 2020; 39(3): 175–240.
  2. Villalta S, Bagatella P, Piccioli A, et al. Assessment of validity and reproducibility of a clinical scale for the postthrombotic syndrome. Haemostasis. 1994; 24: 158a.
  3. Kahn SR. Frequency and determinants of the postthrombotic syndrome after venous thromboembolism. Curr Opin Pulm Med. 2006; 12(5): 299–303.
  4. Kahn SR, Comerota AJ, Cushman M, et al. American Heart Association Council on Peripheral Vascular Disease, Council on Clinical Cardiology, and Council on Cardiovascular and Stroke Nursing. The postthrombotic syndrome: evidence-based prevention, diagnosis, and treatment strategies: a scientific statement from the American Heart Association. Circulation. 2014; 130(18): 1636–1661.
  5. Kahn SR, Comerota AJ, Cushman M, et al. American Heart Association Council on Peripheral Vascular Disease, Council on Clinical Cardiology, and Council on Cardiovascular and Stroke Nursing. The postthrombotic syndrome: evidence-based prevention, diagnosis, and treatment strategies: a scientific statement from the American Heart Association. Circulation. 2014; 130(18): 1636–1661.
  6. Kahn SR, Galanaud JP, Vedantham S, et al. Guidance for the prevention and treatment of the post-thrombotic syndrome. J Thromb Thrombolysis. 2016; 41(1): 144–153.
  7. Rabinovich A, Kahn SR. How to predict and diagnose postthrombotic syndrome. Pol Arch Med Wewn. 2014; 124(7-8): 410–416.
  8. Galanaud JP, Bertoletti L, Amitrano M, et al. RIETE registry investigators. Predictors of Post-Thrombotic Ulcer after Acute DVT: The RIETE Registry. Thromb Haemost. 2018; 118(2): 320–328.
  9. Tick LW, Kramer MHH, Rosendaal FR, et al. Risk factors for post-thrombotic syndrome in patients with a first deep venous thrombosis. J Thromb Haemost. 2008; 6(12): 2075–2081.
  10. van Dongen CJJ, Prandoni P, Frulla M, et al. Relation between quality of anticoagulant treatment and the development of the postthrombotic syndrome. J Thromb Haemost. 2005; 3(5): 939–942.
  11. Chitsike RS, Rodger MA, Kovacs MJ, et al. Risk of post-thrombotic syndrome after subtherapeutic warfarin anticoagulation for a first unprovoked deep vein thrombosis: results from the REVERSE study. J Thromb Haemost. 2012; 10(10): 2039–2044.
  12. van Dongen CJJ, Prandoni P, Frulla M, et al. Relation between quality of anticoagulant treatment and the development of the postthrombotic syndrome. J Thromb Haemost. 2005; 3(5): 939–942.
  13. Kahn SR, Shrier I, Julian JA, et al. Determinants and time course of the postthrombotic syndrome after acute deep venous thrombosis. Ann Intern Med. 2008; 149(10): 698–707.
  14. Labropoulos N, Jen J, Jen H, et al. Recurrent deep vein thrombosis: long-term incidence and natural history. Ann Surg. 2010; 251(4): 749–753.
  15. Bouman AC, Smits JJM, Ten Cate H, et al. Markers of coagulation, fibrinolysis and inflammation in relation to post-thrombotic syndrome. J Thromb Haemost. 2012; 10(8): 1532–1538.
  16. Luzzi R, Belcaro G, Dugall M, et al. The efficacy of sulodexide in the prevention of postthrombotic syndrome. Clin Appl Thromb Hemost. 2014; 20(6): 594–599.
  17. Kearon C, Akl EA, Ornelas J, et al. Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report. Chest. 2016; 149(2): 315–352.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl